BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25733220)

  • 1. 24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions.
    de Donato G; Bosiers M; Setacci F; Deloose K; Galzerano G; Verbist J; Peeters P; Setacci C
    Ann Vasc Surg; 2015; 29(4):738-50. PubMed ID: 25733220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAVISSIMO study: 12-month results from the TASC A/B subgroup.
    Bosiers M; Deloose K; Callaert J; Verbist J; Keirse K; Peeters P
    J Cardiovasc Surg (Torino); 2012 Feb; 53(1):91-9. PubMed ID: 22071471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results.
    Deloose K; Bosiers M; Callaert J; Verbist J; Vermassen F; Scheinert D; Torsello G; Peeters P
    J Cardiovasc Surg (Torino); 2017 Jun; 58(3):416-421. PubMed ID: 25331010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions.
    Piazza M; Squizzato F; Spolverato G; Milan L; Bonvini S; Menegolo M; Grego F; Antonello M
    J Vasc Surg; 2015 Nov; 62(5):1210-8.e1. PubMed ID: 26254822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
    Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II.
    Ichihashi S; Higashiura W; Itoh H; Sakaguchi S; Nishimine K; Kichikawa K
    J Vasc Surg; 2011 Apr; 53(4):992-9. PubMed ID: 21215582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAVISSIMO: 12-month results from a large scale prospective trial.
    Bosiers M; Deloose K; Callaert J; Maene L; Beelen R; Keirse K; Verbist J; Peeters P; Schroë H; Lauwers G; Lansink W; Vanslembroeck K; D'archambeau O; Hendriks J; Lauwers P; Vermassen F; Randon C; Van Herzeele I; De Ryck F; De Letter J; Lanckneus M; Van Betsbrugge M; Thomas B; Deleersnijder R; Vandekerkhof J; Baeyens I; Berghmans T; Buttiens J; Van Den Brande P; Debing E; Rabbia C; Ruffino A; Tealdi D; Nano G; Stegher S; Gasparini D; Piccoli G; Coppi G; Silingardi R; Cataldi V; Paroni G; Palazzo V; Stella A; Gargiulo M; Muccini N; Nessi F; Ferrero E; Pratesi C; Fargion A; Chiesa R; Marone E; Bertoglio L; Cremonesi A; Dozza L; Galzerano G; De Donato G; Setacci C
    J Cardiovasc Surg (Torino); 2013 Apr; 54(2):235-53. PubMed ID: 23558659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
    Kudo T; Chandra FA; Ahn SS
    J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.
    Bosiers M; Deloose K; Callaert J; Moreels N; Keirse K; Verbist J; Peeters P
    J Vasc Surg; 2011 Oct; 54(4):1042-50. PubMed ID: 21636239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.
    Malas MB; Enwerem N; Qazi U; Brown B; Schneider EB; Reifsnyder T; Freischlag JA; Perler BA
    J Vasc Surg; 2014 Jan; 59(1):129-35. PubMed ID: 23891488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editor's Choice - Outcomes of Self Expanding PTFE Covered Stent Versus Bare Metal Stent for Chronic Iliac Artery Occlusion in Matched Cohorts Using Propensity Score Modelling.
    Piazza M; Squizzato F; Dall'Antonia A; Lepidi S; Menegolo M; Grego F; Antonello M
    Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):177-185. PubMed ID: 28487112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covered versus bare metal kissing stents for reconstruction of the aortic bifurcation in the ILIACS registry.
    Squizzato F; Piazza M; Pulli R; Fargion A; Piffaretti G; Pratesi C; Grego F; Antonello M;
    J Vasc Surg; 2021 Jun; 73(6):1980-1990.e4. PubMed ID: 33253875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions.
    Tewksbury R; Taumoepeau L; Cartmill A; Butcher A; Cohen T
    Vascular; 2015 Dec; 23(6):630-6. PubMed ID: 25819513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical experience with the Innova versus the Protege EverFlex self-expanding bare metal stents in superficial femoral artery occlusions.
    Gabrielli R; Rosati MS; Chiappa R; Millarelli M; Marcuccio L; Siani A; Caselli G
    Thorac Cardiovasc Surg; 2015 Mar; 63(2):158-63. PubMed ID: 25602844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of demographic factors and lesion severity on iliac stent patency.
    Roach AN; Larion S; Ahanchi SS; Ammar CP; Brandt CT; Dexter DJ; Panneton JM
    J Vasc Surg; 2015 Sep; 62(3):645-53. PubMed ID: 26094046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent.
    Bontinck J; Goverde P; Schroë H; Hendriks J; Maene L; Vermassen F
    J Vasc Surg; 2016 Nov; 64(5):1311-1319. PubMed ID: 27462002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.